ARTICLE | Clinical News
Spiriva Respimat tiotropium bromide: Phase III data
September 19, 2016 7:00 AM UTC
Top-line data from the double-blind, international Phase III PensieTinA-asthma trial in 392 patients ages 12-17 with severe symptomatic asthma who were taking an inhaled corticosteroid with 1-2 other ...